News Release – EU Clinical Study

Protembis announces completion of 20 cases in European CE mark study with the ProtEmbo® Cerebral Protection System Enrollment with advanced generation device for complete cerebral protection nearing halfway mark in clinical study in Germany and Poland Aachen, Germany, February 25, 2021 Protembis GmbH, a privately held emerging medical device company, announced today the successful completion … Weiterlesen …

News Release – First in Human

Protembis announces successful first-in-human use of its ProtEmbo®Cerebral Protection System in European trial